Mohamed Abd Elaziz Metwally Ali|Publications

You are in:Home/Publications
Prof. Mohamed Abd Elaziz Metwally Ali :: Publications:

Research Fields

hepatitis

patients

chronic HCV

hepatic fibrosis

prediction

liver

serum

Number of publications is 34

Title

1-A scoring model for prediction of relapse among chronic HCV genotype 4 patients treated with peginterferon and ribavirin.

2-Previous and silent hepatitis B infection in patients with chronic hepatitis C: Risk factors for severe hepatic fibrosis.

3-A Simple Non-invasive Scoring System for Prediction of Severe Hepatic Fibrosis in Chronic HCV Patients Co-infected with HIV

4-Role of serum leptin in patients with liver cirrhosis and hepatocellular carcinoma complicating chronic viral hepatitis.

5-High body mass index is associated with advanced hepatic fibrosis in patients chronic hepatitis C. Journal of Hepatology 2002; 36, Suppl 1, 240. (Presented in the Eurobean Association of Study of Liver Diseases and Intenational Association of Study of Liver Disease annual meeting, 2001, Madrid, Spain). Primary author

6-Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin

Abstract

7-Pulmonary functions after injection sclerotherapy of esophageal varices and after band ligation.

8-High insulin resistance is associated with low rapid virological response in chronic HCV patients.

9-CSF lactate: A rapid accurate diagnostic test for acute bacterial meningitis.

Abstract

10-Serum ferritin level as a predictor of response to pegylated interferon/ribavirin therapy in Egyptian chronic hepatitis C patients.

11-Prediction of relapse among chronic HCV genotype 4 patients treated with PEG-IFN and Ribavirine.

12-Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants.

Abstract' | Full paper

13-A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.

Abstract' | Full paper

14-Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.

Abstract' | Full paper

15-. Predictors and non invasive identification of severe liver fibrosis in patients with chronic hepatitis C

Abstract' | Full paper

16-Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.

Abstract' | Full paper

17- Reliability and validity of urine screening leukocyte esterase strips in diagnosis of spontaneous bacterial peritonitis.

18-Elevation of pancreatic enzymes in patients with chronic liver diseases. (Presented at the IASL/AFASLD meeting, 2006, Cairo, Egypt)

19-Histopathological characterization of genotype 4 chronic hepatitis C.

20-Neurophysiologic and psychometric changes in patients with liver cirrhosis.

21-Serum level of tumor necrosis factor-alpha in patients with hepatic encephalopathy due to chronic liver diseases.

22-Prevalence and risk factors of hepatitis C among pregnant females in Egypt. (Presented at the IASL/AFASLD meeting, 2006, Cairo, Egypt) Liver International Vol 26 (Suppl 1) September 2006. Primary Author.

23-Clinical Significance of Hepatic Iron Deposition and Serum Iron Values in Patients with Chronic Hepatitis C Infection

Full paper

24-Regression of Fibrosis and Cirrhosis in Chronic HCV Patients Treated with Interferon Based Therapy

25-Comparison of the VERSANT HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy

Abstract' | Full paper

26-Tumor necrosis alpha promoter gene polymorphisms and diabetes in patients with chronic hepatitis C: Evidence in favor of an association.

27-Hepatitis C virus infection as a risk factor for development of type 2 diabetes mellitus: A prospective cross-sectional study.

28- Does Normal ALT Exclude Severe Hepatic Fibrosis in Patients with Chronic Hepatitis C? Gastroenterology 2002; Suppl A 631. (Oral presentation in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA) Primary author

29- Does High Body Mass Index Affect Hepatic Fibrosis, Steatosis, and Inflammation in Patients with Chronic Hepatitis C? Gastroenterology 2002; 123, 1 Suppl: Pg. 52 A M1632. (Presented in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA). Primary author

30-A Simple Non-invasive Scoring System for Prediction of Severe Hepatic Fibrosis in Chronic HCV Patients Co-infected with HIV. Gastroenterology 2002; 123, 1 Suppl: pg. 50 A M1621. (Presented in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA). Primary author

31-Comparison of Detection of Hepatitis C Virus (HCV) by Transcription-Mediated Amplification (TMA) versus COBAS AMPLICOR™ HCV Test, version 2.0 (AMPLICOR) in Patients Undergoing Antiviral Therapy. (Presented in the American Association of Study of Liver Diseases annual meeting, 2002, Boston, Massachusetts, USA). Co-author.

32-A population based epidemiological study of Helicobacter Pylori in Egypt.

33-Independent predictors of severe liver fibrosis in chronic hepatitis C.

34-Significance of Hepatic Iron Deposition and Serum Iron Indices in Liver Fibrosis Associated with Chronic Hepatitis C.

Prof. Mohamed Abd Elaziz Metwally Ali :: Publications: